MacuLogix Names Christine Silverberg as Director of National Accounts


HARRISBURG, Pa.—MacuLogix Inc., a company that equips eyecare professionals with instruments, tools and education to effectively diagnose and treat patients with age-related macular degeneration (AMD), appointed Christine Silverberg, MBA, BSN, RN, as director of national accounts. In this role, Silverberg will lead business development and partnerships across the industry to make “dark adaptation” testing more readily available to consumers across the U.S., according to an announcement earlier this week. “Christine brings a depth and breadth of experience calling on the C-Suites of major independent delivery networks and accountable care organizations in the U.S.,” president and chief executive officer William McPhee said in the announcement. “Her knowledge of population health, business operations and data analytics to execute successful programs in corporate settings will be invaluable in supporting our mission.”

Silverberg comes to MacuLogix from the Vision Care Division of Hill-Rom Holdings Inc. She has been a major contributor and award-achieving sales professional at a variety of well-known companies, including Fuji Film, Ethicon Endo-Surgery, Aesculap and Athena Diagnostics, for the past 15 years. Silverberg earned her BSN from the University of Washington and her MBA with a graduate certificate in applied finance from Colorado State University.

“I’m excited to be part of a fast-growing organization that has introduced a new standard of care in the diagnosis and treatment of age-related macular degeneration,” she said. “I look forward to leveraging my experiences to benefit large health care organizations as well as consumers.”